Immunovant, Inc. number of employees

Immunovant, Inc. reported 315 employees at March 31, 2026 in its latest annual report.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
March 31, 2026	315	—	—	10-K, filed May 20, 2026

What the annual reports say

We believe if our employees are well aligned with our values and culture, they will be highly engaged, which will support their performance and impact on the organization. 47 Table of Contents Employees As of March 31, 2026, we had 315 full-time permanent employees, primarily in the U.S. 2026 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Immunovant, Inc.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Immunovant, Inc.